{
  "package" : "hl7.fhir.r4.examples@4.0.1",
  "definition" : "Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.\\r\\n\\n                        \\n                           Examples: \\n                        \\r\\n\\n                        \\n                           ranitidine for Tagamet",
  "system" : "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
  "property" : [ {
    "_uri" : "http://hl7.org/fhir/concept-properties#child",
    "code" : "child",
    "_implicit" : true,
    "valueCode" : "TG"
  }, {
    "_uri" : "http://hl7.org/fhir/concept-properties#child",
    "code" : "child",
    "_implicit" : true,
    "valueCode" : "TB"
  }, {
    "_uri" : "http://hl7.org/fhir/concept-properties#parent",
    "code" : "parent",
    "_implicit" : true,
    "valueCode" : "E"
  } ],
  "codesystem" : "354dd316-e3e7-5795-8e1f-62e7648a955b",
  "concept_id" : "ce7f31ef-7226-5c35-8c2e-11b35d5e3d4a",
  "ancestors" : {
    "E" : 1,
    "TE" : 0,
    "_ActSubstanceAdminSubstitutionCode" : 2
  },
  "id" : "c248a62b-5c76-4356-a9e4-b9d3303fafbc",
  "code" : "TE",
  "display" : "therapeutic alternative",
  "version" : "2018-08-12"
}